Sign In
News Digest /
Ticker: ALDX
Ticker: ALDX
06:07pm, Wednesday, May 14, 2025
Company Overview: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is a clinical-stage biotechnology company dedicated to developing innovative therapies for immune-mediated and metabolic diseases. As of March 31, 2025, the company reported a net loss of approximately $9.93 million.
Financial Summary:
...
05:43am, Thursday, Sep 19, 2024
Key earnings announcements on September 19, 2024, include Lennar Corp, Darden Restaurants, FactSet, FedEx, and MillerKnoll. Stay updated on these reports that may influence market trends and investor decisions.
